|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Sep―17 |
Local and systemic side effects of COVID-19 vaccine in Tunisian cancer patients: A prospective single center study |
Wala Ben Kridis, Olfa Boudawara, Afef Khanfir |
2 |
[GO] |
2024―Mar―08 |
Pharmacist's role in the management of drug-drug interactions caused by nirmatrelvir/ritonavir in COVID-19 oncohematology patients |
Carlos Guzmán Cordero, María Sáez-Torres de Vicente, Álvaro Jiménez Espinosa, Ana Isabel Gago Sánchez |
3 |
[GO] |
2022―Jan―11 |
Impact of the COVID-19 pandemic on new starts to oral oncology medications in the US |
Lynn Neilson, Monal Kohli, Kiraat D Munshi, Samuel K Peasah, Rochelle Henderson, Vida Passero, Chester B Good |
4 |
[GO] |
2021―Dec―14 |
The experience of cancer patients during the COVID-19 pandemic |
Melanie Dalby, Nikant Ailawadi |
5 |
[GO] |
2021―Oct―23 |
Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners |
Grace Chazan, Jennifer Jupp, Tiene Bauters, Nick Duncan, Kellie Jones Weddle, Hisanaga Nomura, et al. (+19) Shaun O’Connor, Alexandre Chan, Nora Alkhudair, Majed Alshamrani, Larry W Buie, Pinkie Chambers, Tan Wen Chieh, David L DeRemer, France Duvivier, Deogratias Katabalo, Thomas McFarlane, Daniel Mckavanagh, Kofi Mensah, Estela Moreno Martinez, Gail Rowan, Manit Sae-teaw, Tamrat Assefa Tadesse, Irene Weru, Marliese Alexander |
6 |
[GO] |
2021―Oct―13 |
Potential interactions between antineoplastic agents and medicines used to treat Covid-19 |
Mario Jorge Sobreira da Silva, Claudia Garcia Serpa Osorio-de-Castro, Rafael Duarte Paes, Christopher Lucas Negrete, Elizangela Eugênio, Elaine Lazzaroni Moraes, Annemeri Livinalli |
7 |
[GO] |
2021―Sep―30 |
Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards |
Deniz C Guven, Imdat Eroglu, Rashad Ismayilov, Ege Ulusoydan, Oktay H Aktepe, Gulcin Telli Dizman, et al. (+5) Zafer Arik, Omer Dizdar, Serhat Unal, Gokhan Metan, Neyran Kertmen |
8 |
[GO] |
2021―Sep―25 |
Acceptance of coronavirus disease 2019 vaccination by cancer patients in Cyprus: A cross-sectional study |
Zoe Roupa, Maria Noula, Monica Nikitara, Savoula Ghobrial, Evangelos Latzourakis, Giannis Polychronis |
9 |
[GO] |
2021―Aug―23 |
Alectinib, COVID-19 and favipiravir |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
10 |
[GO] |
2021―May―13 |
Global changes to the chemotherapy service during the covid-19 pandemic |
Man-Chie Chow, Pinkie Chambers, Georgina Singleton, Jignesh Patel, Silvie Cooper, Charlotte Mythen, et al. (+6) Elysse Bautista-González, Georgia Chisnall, Nehla Djellouli, Benjamin Thwaites, Ian CK Wong, Cecilia Vindrola-Padros |
11 |
[GO] |
2021―May―09 |
Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? |
Murat Ayhan, Şahin Laçin, Deniz T Özyükseler, Heves Sürmeli, Akif Doğan, Merve Turan, et al. (+3) Hatice odabas, Nedim Turan, Mahmut Emre Yıldırım |
12 |
[GO] |
2021―Apr―24 |
Immune-checkpoint inhibitor toxicity during a pandemic: Overcoming patient fears to provide care. A case report |
Christopher T Elder, Elizabeth C Davis, Stephanie Jaipal, Charles E Wight |
13 |
[GO] |
2021―Feb―11 |
Development of a process map for the delivery of virtual clinical pharmacy services at Odette Cancer Centre during the COVID-19 pandemic |
Maria Marchese, Angela Heintzman, Mark Pasetka, Flay Charbonneau, Carlo DeAngelis, Christine Peragine |
14 |
[GO] |
2021―Jan―28 |
Cancer patient experience of telephone clinics implemented in light of COVID-19 |
Melanie Dalby, Alison Hill, Shereen Nabhani-Gebara |
15 |
[GO] |
2021―Jan―20 |
Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle? |
Emre Yekedüz, Güngör Utkan, Yüksel Ürün |
16 |
[GO] |
2021―Jan―18 |
Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City |
Prakirthi Yerram, Jennifer Thackray, Lisa R Modelevsky, Josiah D Land, Samantha N Reiss, Krisoula H Spatz, et al. (+18) Andrea C Levoir, Terry K Pak, Phuong H Dao, Michael J Buege, Lauren M Derespiris, Carmen Lau, Jennifer S Orozco, Manpreet Boparai, Lauren A Koranteng, Kate E Reichert, Shirley Q Yan, Nicole P Daukshus, Sherry Mathew, Larry W Buie, Richard F Tizon, Scott Freeswick, Dazhi Liu, Stephen Harnicar |
17 |
[GO] |
2020―Nov―02 |
Coping with the residency program during COVID-19: Hematology oncology pharmacy residents’ perspective |
Aeshah A AlAzmi, Fouad AlNajjar, Majed AlShomrani |
18 |
[GO] |
2020―Oct―23 |
Response of an oncology unit in the midst of the COVID-19 outbreak |
Michalis Liontos, Efstathios Kastritis, Magdalini Migkou, Konstantinos Koutsoukos, Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, et al. (+4) Theodora Psaltopoulou, Flora Zagouri, Evangelos Terpos, Meletios Athanasios Dimopoulos |
19 |
[GO] |
2020―Oct―21 |
Tyrosine kinase inhibitors and COVID-19 |
Başcı Semih, Yiğenoğlu Tuğçe Nur, Dal Mehmet Sinan, Korkmaz Serdal, Turgut Burhan, Altuntaş Fevzi |
20 |
[GO] |
2020―Oct―21 |
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors |
Banu Cakir |
21 |
[GO] |
2020―Oct―08 |
Optimizing the role of ambulatory chemotherapy in response to the Covid-19 pandemic |
Racha Sabbagh Dit Hawasli, Shereen Nabhani-Gebara |
22 |
[GO] |
2020―Sep―29 |
A practical approach to the management of colorectal cancer during the COVID-19 crisis in the reference cancer treatment center in Tunisia |
Feriel Letaief, Imen Gharbi, Adel Hamdi, Yosra Yahyaoui, Mona Ayadi, Imen Blousa, Amel Mezlini |
23 |
[GO] |
2020―Sep―25 |
Clinical strategies for optimizing infusion center care through a pandemic |
Kirollos S Hanna, Eve M Segal, Ashley Barlow, Brooke Barlow |
24 |
[GO] |
2020―Aug―28 |
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors |
Semih Başcı, Naim Ata, Fevzi Altuntaş, Tuğçe Nur Yiğenoğlu, Mehmet Sinan Dal, Serdal Korkmaz, et al. (+13) Sinem Namdaroğlu, Abdülkadir Baştürk, Tuba Hacıbekiroğlu, Mehmet Hilmi Doğu, İlhami Berber, Kürşat Dal, Mehmet Ali Erkurt, Burhan Turgut, Murat Çağlayan, Mustafa Okan Ayvalı, Osman Çelik, Mustafa Mahir Ülgü, Şuayip Birinci |
25 |
[GO] |
2020―Aug―14 |
Switch in use of midazolam for cancer patients during the COVID-19 pandemic |
Guillaume Marliot, Nicolas Penel, Vincent Gamblin |
26 |
[GO] |
2020―Aug―14 |
Suggestion of Tunisia’s medical oncologist in the management of breast cancer during COVID-19 pandemic |
Yosra Yahyaoui, Zahra Ghodhbani, Adel Hamdi, Feryel Letaief, Yosr Zenzri, Azza Ben Said, et al. (+2) Imen Blouza, Amel Mezlini |
27 |
[GO] |
2020―Jul―06 |
Are we aware of potential interactions between drugs used in lung cancer and drugs used in the treatment of COVID-19? |
Elif Aras-Atik, Kamer Tecen-Yucel, Aygin Bayraktar-Ekincioglu |
28 |
[GO] |
2020―Jun―25 |
Practical strategies to manage cancer patients during the COVID-19 pandemic: Saudi Oncology Pharmacy Assembly Experts recommendations |
Majed Alshamrani, Atika AlHarbi, Nora Alkhudair, Fouad AlNajjar, Mansoor Khan, Abdulaziz Ben Obaid, et al. (+6) Amr Khardaly, Eshtyag Bajnaid, Hadeel Samarkandi, Aeshah AlAzmi, Salman Alabdali, Mohammed AlNahedh |
29 |
[GO] |
2020―Jun―07 |
Routine antiemetic prophylaxis with dexamethasone during COVID-19: Should oncologists reconsider? |
Mark A Marinella |
30 |
[GO] |
2020―May―29 |
Use of personal protective equipment while admixing antineoplastic drugs during the COVID-19 pandemic era: Questionnaire survey in Niigata, Japan |
Satoru Mitsuboshi, Masaki Yoshino, Hiroki Hosokawa, Hirokazu Isobe, Kenichi Kobayashi |
31 |
[GO] |
2020―May―19 |
Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab |
Emre Yekedüz, Bengü Dursun, Güle Ç Aydın, Satı C Yazgan, Halis H Öztürk, Alpay Azap, et al. (+2) Güngör Utkan, Yüksel Ürün |
32 |
[GO] |
2020―May―15 |
Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety |
Marliese Alexander, Jennifer Jupp, Grace Chazan, Shaun O’Connor, Alexandre Chan |